セッション

RUNX2 super enhancer promotes the development of blastic plasmacytoid dendritic cell neoplasm

[演者] Sho Kubota (久保田 翔):1
[著者] Kenji Tokunaga (徳永 賢治):2, Motohiko Oshima (大島 基彦):3, Tomohiro Umezu (梅津 知宏):4, Akinori Kanai (金井 昭教):5, Kar Ton Tan:6, Henry Yang:6, Eisaku Iwanaga (岩永 栄作):2, Norio Asou (麻生 範雄):7, Takahiro Maeda (前田 隆浩):8, Atsushi Iwama (岩間 厚志):3, Kazuma Ohyashiki (大屋敷 一馬):4, Motomi Osato (大里 元美):1,6, Goro Sashida (指田 吾郎):1
1:International Research Center for Medical Sciences, Kumamoto University, 2:Department of Hematology, Kumamoto University, 3:Department of Cellular and Molecular Medicine, Chiba University, 4:Department of Hematology, Tokyo Medical University, 5:Research Institute of Radiation Biology and Medicine, Hiroshima University, 6:Cancer Science Institute of Singapore, National University of Singapore, 7:Dept. Hematology, International Med. Center, Saitama Med. Univ., 8:Department of Community Medicine, Nagasaki University

Non-functional BCR-ABL contributes to fluctuating MRD in CML patients after cessation of TKI therapy

[演者] Junichiro Yuda (湯田 淳一朗):1
[著者] Toshihiro Miyamoto (宮本 敏浩):1, Jun Odawara (小田原 淳):1, Mariko Minami (南 満理子):1, Yasuyuki Ohkawa (大川 恭行):2, Koichi Akashi (赤司 浩一):1
1:Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 2:Department of Advanced Medical Initiatives, Kyushu University, Fukuoka, Japan

詳細検索